Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Robert Asaba"'
Autor:
Jonathan Kitonsa, Onesmus Kamacooko, Ubaldo Mushabe Bahemuka, Freddie Kibengo, Ayoub Kakande, Anne Wajja, Vincent Basajja, Alfred Lumala, Edward Ssemwanga, Robert Asaba, Joseph Mugisha, Benjamin F Pierce, Robin Shattock, Pontiano Kaleebu, Eugene Ruzagira
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
BackgroundHealthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials
Externí odkaz:
https://doaj.org/article/b612cbc71c1c4a71a887a2b9f28a3f8c
Autor:
Eugene Ruzagira, Edward Ssemwanga, Benjamin F. Pierce, Pontiano Kaleebu, Anne Wajja, Robert Asaba, Onesmus Kamacooko, Freddie Kibengo, Paddy Kafeero, Alfred Lumala, Jonathan Kitonsa, Vincent Basajja, Robin J. Shattock, Ubaldo Bahemuka, Joseph Mugisha, Ayoub Kakande
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 18
Issue 13
International Journal of Environmental Research and Public Health, Vol 18, Iss 7004, p 7004 (2021)
Volume 18
Issue 13
International Journal of Environmental Research and Public Health, Vol 18, Iss 7004, p 7004 (2021)
Healthcare workers (HCWs) are at high risk of COVID-19. However, data on HCWs’ knowledge, attitudes, and practices (KAP) toward COVID-19 are limited. Between September and November 2020, we conducted a questionnaire-based COVID-19 KAP survey among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4b21e907434c466ad272c1ae8ade3b
Autor:
Vincent Basajja, Eugene Ruzagira, Ubaldo Bahemuka, Pontiano Kaleebu, Anne Wajja, Jonathan Kitonsa, Robert Asaba, Edward Ssemwanga, Freddie Kibengo, Onesmus Kamacooko, Ayoub Kakande, Benjamin F. Pierce, Joseph Mugisha, Robin J. Shattock, Alfred Lumala
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
Background Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a16336206791b0aeced2d3b176f5ec
http://europepmc.org/articles/PMC8158909
http://europepmc.org/articles/PMC8158909
Autor:
Slivesteri S; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda., Ssali A; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda.; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom., Bahemuka UM; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda., Nsubuga D; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda., Muwanga M; Entebbe Regional Referral Hospital, Wakiso, Uganda., Nsereko C; Entebbe Regional Referral Hospital, Wakiso, Uganda., Ssemwanga E; Villa Maria Hospital, Kalungu, Uganda., Robert A; Our Lady of Consolata, Kisubi Hospital, Wakiso, Uganda., Seeley J; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda.; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom., Elliott A; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom., Ruzagira E; MRC/UVRI & LSHTM Uganda Research Unit, Wakiso, Uganda.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2024 May 29; Vol. 4 (5), pp. e0002188. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).